References
- Sbiera S, Schmull S, Assie G, Voelker H-U, Kraus L, Beyer M, Ragazzon B, Beuschlein F, Willenberg HS, Hahner S, et al. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. J Clin Endocrinol Metab 2010; 95:E161-171; PMID:20660055; http://dx.doi.org/10.1210/jc.2010-0653
- Doghman M, Karpova T, Rodrigues GA, Arhatte M, De Moura J, Cavalli LR, Virolle V, Barbry P, Zambetti GP, Figueiredo BC, et al. Increased steroidogenic factor-1 dosage triggers adrenocortical cell proliferation and cancer. Mol Endocrinol 2007; 21:2968-2987; PMID:17761949; http://dx.doi.org/10.1210/me.2007-0120
- Doghman M, Figueiredo BC, Volante M, Papotti M, Lalli E. Integrative analysis of SF-1 transcription factor dosage impact on genome-wide binding and gene expression regulation. Nucl Acids Res 2013; 41:8896-8907; PMID:23907384; http://dx.doi.org/10.1093/nar/gkt658
- Doghman-Bouguerra M, Granatiero V, Sbiera S, Sbiera I, Lacas-Gervais S, Brau F, Fassnacht M, Rizzuto R, Lalli E. FATE1 antagonizes calcium− and drug− induced apoptosis by uncoupling ER and mitochondria. EMBO Rep 2016; PMID:27402544; http://dx.doi.org/10.15252/embr.201541504
- Simpson AJG, Caballero OL, Jungbluth A, Chen Y-T, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5:615-625; PMID:16034368; http://dx.doi.org/10.1038/nrc1669
- van der Laan M, Bohnert M, Wiedemann N, Pfanner N. Role of MINOS in mitochondrial membrane architecture and biogenesis. Trends Cell Biol 2012; 22:185-192; PMID:22386790; http://dx.doi.org/10.1016/j.tcb.2012.01.004
- Whitehurst AW, Bodemann BO, Cardenas J, Ferguson D, Girard L, Peyton M, Minna JD, Michnoff C, Hao W, Roth MG, et al. Synthetic lethal screen identification of chemosensitizer loci in cancer cells. Nature 2007; 446:815-819; PMID:17429401; http://dx.doi.org/10.1038/nature05697